disease 1,161 words KG: ent-dise-46c0797d 2026-03-31
kind:diseasesection:diseasesstate:published
Contents

Tau PET Imaging in Corticobasal Syndrome

Disease Info
Binding mechanismFlortaucipir binds to the microtubule-binding repeat domain of PHF-tau, showing selectivity for 3R and 4R tau aggregates
Off-target bindingKnown off-target binding includes monoamine oxidase B (MAO-B) in the basal ganglia, neuromelanin in the substantia nigra, and off-target binding to amyloid plaques in some cases
KineticsShows steady-state binding potential with reasonable test-retest reliability
[^18F]THK5351Early tau PET tracer with off-target MAO-B binding
[^18F]THK5317 (S-AV-45)Enantiomer of THK5351 with improved binding characteristics
[^11C]PBB3Second-generation tracer with broader tau binding profiles
[^18F]MK-6240High affinity for PHF-tau, reduced off-target binding
[^18F]APN-1607 (Fluoro-PET)Pan-tau tracer with potential for different tau morphologies
[^18F]PI-2620High binding to 3R/4R tau with favorable kinetics
[^18F]RO-948Selective for PHF-tau with minimal off-target
Predominant regionsSuperior frontal gyrus, inferior parietal lobule, superior temporal gyrus
Asymmetry indexHigher contralateral-to-ipsilateral ratio compared to PSP
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph